Dyssynergia Cerebellaris Myoclonica
Dyssynergia Cerebellaris Myoclonica

‹ Return to Disorder Directory

Dyssynergia Cerebellaris Myoclonica


Dyssynergia Cerebellaris Myoclonica refers to a collection of rare, degenerative, neurological disorders characterized by epilepsy, cognitive impairment, myoclonus, and progressive ataxia.  Symptoms include seizures, tremor, and reduced muscle coordination.  Onset of the disorder generally occurs in early adulthood.  Tremor may begin in one extremity and later spread to involve the entire voluntary muscular system.  Arms are usually more affected than legs.  Some of the cases are due to mitochondrial abnormalities.


Treatment of Dyssynergia Cerebellaris Myoclonica is symptomatic.  Myoclonus and seizures may be treated with drugs like valproate.


The progression of the disorder is usually 10 years or longer.


The NINDS supports a broad range of research on neurodegenerative disorders such as Dyssynergia Cerebellaris Myoclonica.  The goals of this research are to find ways to prevent, treat, and cure these kinds of disorders. Information from the National Library of Medicine’s MedlinePlusCerebellar Disorders

Information sourced through CNF’s partnership with The National Institute of Neurological Disorders and Stroke (NINDS), US National Institutes of Health.

Start typing and press Enter to search

Shopping Cart